glp 1 agonist shortage Government declares 'national shortage' of GLP-1 receptor agonists for type 2 diabetes until 2024 Metabolic Consequences of Glucagon-Like Peptide-1

is supported by NINDS grant RF1NS128800, the Michael J

Nat Neurosci

10,17 GLP-1 receptor stimulation in the arcuate nucleus also improves glycemic control independent of feeding behavior

Graphical abstract was created by BioRender ( Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest

Federal spending is expected to increase under this demonstration due to paying for GLP-1s for obesity, which is not currently covered under Medicare, but the amount of the increase is unknown since CMS hasnt disclosed the projected cost

Despite these differences, Semaglutide GLP-1, Ozempic, Wegovy, and Mounjaro can all aid patients in achieving substantial weight loss as part of a comprehensive medical weight management plan